Aspirin
Information
- Drug Name
- Aspirin
- Description
- Entry(CIViC)
- 3
CIViC
| Disease | Mutation | EL | ET | ED | CS | VO | TR | Pubmed | Links |
|---|---|---|---|---|---|---|---|---|---|
| colorectal cancer |
PTGS2 OVEREXPRESSION ( ENST00000367468.10 ) PTGS2 OVEREXPRESSION ( ENST00000367468.10 ) |
B |
Predictive
|
Supports
|
Sensitivity/Response | Somatic | 3 | 17522398 | Detail |
| colorectal cancer | PIK3CA WILD TYPE PIK3CA WILD TYPE | B |
Predictive
|
Does Not Support
|
Sensitivity/Response | Somatic | 3 | 23094721 | Detail |
| colorectal cancer | PIK3CA MUTATION PIK3CA MUTATION | B |
Predictive
|
Supports
|
Sensitivity/Response | Somatic | 3 | 23094721 | Detail |
Annotation
| Description | Associated Genes | Associated Variants | Sensitivity | Supported | Source | Links |
|---|---|---|---|---|---|---|
| Mail-in surveys conducted every two years since 19... | PTGS2 |
PTGS2 OVEREXPRESSION ( ENST00000367468.10 ) PTGS2 OVEREXPRESSION ( ENST00000367468.10 ) |
Sensitivity | true | CIViC Evidence | detail |
| This was a retrospective study of 964 colorectal c... | PIK3CA | PIK3CA WILD TYPE PIK3CA WILD TYPE | Sensitivity | false | CIViC Evidence | detail |
| This was a retrospective study of 964 colorectal c... | PIK3CA | PIK3CA MUTATION PIK3CA MUTATION | Sensitivity | true | CIViC Evidence | detail |
| NCT ID | Status | Phase | Summary | Start date | Completion date |
|---|---|---|---|---|---|
| NCT05209412 | Active, not recruiting | N/A | Paclitaxel-Coated Balloon Versus Zotarolimus-Eluting Stent for Treatment of De Novo Coronary Artery Lesions | February 1, 2022 | February 1, 2025 |
| NCT02521285 | Active, not recruiting | Phase 2 | Aspirin in Preventing Disease Recurrence in Patients With Barrett Esophagus After Successful Elimination by Radiofrequency Ablation | January 15, 2016 | March 5, 2025 |
| NCT03417388 | Active, not recruiting | Phase 4 | Women's IschemiA TRial to Reduce Events In Non-ObstRuctive CAD | February 9, 2018 | December 30, 2024 |
| NCT02394769 | Active, not recruiting | N/A | ASPirin Intervention for the REDuction of Colorectal Cancer Risk | July 6, 2015 | July 2029 |
| NCT02467582 | Active, not recruiting | Phase 3 | Adjuvant Aspirin Treatment for Colon Cancer Patients | June 9, 2016 | December 2024 |
| NCT02965703 | Active, not recruiting | Phase 2 | Aspirin in Preventing Colorectal Cancer in Patients With Colorectal Adenoma | January 16, 2018 | July 31, 2024 |
| NCT00135226 | Active, not recruiting | Phase 4 | ASCEND: A Study of Cardiovascular Events iN Diabetes | March 2005 | July 31, 2037 |
| NCT03805932 | Active, not recruiting | Phase 1 | Moxetumomab Pasudotox-tdfk (Lumoxiti(TM)) and Either Rituximab (Rituxan(R)) or Ruxience for Relapsed Hairy Cell Leukemia | October 3, 2019 | June 30, 2025 |
| NCT03377543 | Active, not recruiting | Early Phase 1 | Sleep and Inflammatory Resolution Pathway | June 6, 2018 | December 1, 2024 |
| NCT03197779 | Completed | Phase 1 | A Short and Long Intravenous Infusion Study to Evaluate the Safety, Pharmacokinetics, and Pharmacodynamics of BMS-962212 in Healthy Subjects | November 18, 2013 | January 24, 2017 |
| NCT03807921 | Completed | Phase 4 | Anticoagulation for Aortic Bioprosthesis (ANTIPRO) | January 1, 2019 | December 31, 2019 |
| NCT03248401 | Completed | Phase 4 | Effect of Cilostazol on Carotid Atherosclerosis Estimated by 3D Ultrasound in Patients With Type 2 Diabetes | September 26, 2016 | December 31, 2019 |
| NCT00234065 | Completed | Phase 4 | Post-marketing Study of Cilostazol (Cilostazol Stroke Prevention Study 2) | December 2003 | December 2008 |
| NCT03316534 | Completed | Phase 2 | Effect of Aspirin on Abacavir-induced Platelet Reactivity in HIV-infected Patients | January 2, 2017 | October 12, 2017 |
| NCT03794336 | Completed | Phase 4 | Efficacy and Safety of Alogliptin vs. Acarbose in Chinese Type 2 Diabetes Mellitus (T2DM) Patients With High CV Risk or CHD Treated With Aspirin and Inadequately Controlled With Metformin Monotherapy or Drug Naive | June 29, 2019 | December 14, 2020 |
| NCT03341390 | Completed | Phase 1 | An Investigational Study to Assess the Effect of BMS-986177 on Aspirin in Healthy Participants | October 18, 2017 | November 16, 2017 |
| NCT03766581 | Completed | Phase 2 | A Study on BMS-986177 for the Prevention of a Stroke in Patients Receiving Aspirin and Clopidogrel | January 27, 2019 | March 31, 2022 |
| NCT03370848 | Completed | Phase 4 | Effects of Psyllium on Niacin Tolerability | March 2009 | July 2011 |
| NCT02325466 | Completed | Phase 3 | Comparative Efficacy of Ticagrelor Versus Aspirin on Blood Viscosity in Peripheral Artery Disease Patients With Type 2 Diabetes | April 2015 | May 4, 2018 |
| NCT03093207 | Completed | Phase 2/Phase 3 | Omega-3 Fatty Acids Plus Low-dose Aspirin Daily Supplementation in Surgical Therapy to Treat Aggressive Periodontitis | May 15, 2017 | June 29, 2020 |
| NCT03093246 | Completed | Phase 2/Phase 3 | Omega-3 Plus Low-dose Aspirin Daily Supplementation in Non-surgical Therapy to Treat Aggressive Periodontitis | May 15, 2017 | December 13, 2019 |
| NCT03116269 | Completed | Phase 4 | The Effect of Cilostazol Compared to Aspirin on Endothelial Function in Acute Cerebral Ischemia Patients | March 1, 2012 | October 31, 2014 |
| NCT03871517 | Completed | Phase 4 | INdobufen Versus aSpirin in acUte Ischemic stRokE,INSURE | June 3, 2019 | December 1, 2022 |
| NCT00224809 | Completed | N/A | Impact of Medical and Surgical Therapy on Functional Mitral Regurgitation | September 2002 | May 2007 |
| NCT03869268 | Completed | Phase 4 | The Impact of Aspirin Dose Modification on the Innate Immune Response - Will Lower Dose Aspirin Therapy Reduce the Response to Endotoxin | April 24, 2019 | February 9, 2023 |
| NCT03188705 | Completed | Phase 4 | CES1 Carriers in the PAPI Study | October 14, 2019 | January 17, 2020 |
| NCT03192059 | Completed | Phase 2 | Study of Pembrolizumab, Radiation and Immune Modulatory Cocktail in Cervical/Uterine Cancer | July 1, 2017 | June 30, 2021 |
| NCT02251795 | Completed | Phase 1 | Effects of Steady State Tipranavir/Ritonavir or Darunavir/Ritonavir or Ritonavir on Platelet Function, Coagulation and Fibrinolysis Biomarkers in Healthy Subjects | August 2007 | |
| NCT02266030 | Completed | Phase 3 | Effect of Cilostazol on Coronary Artery Stenosis and Plaque Characteristics in Patients With T2DM | February 2011 | November 2016 |
| NCT02268565 | Completed | Early Phase 1 | Preventing the Inflammatory Response to Experimentally-induced Insomnia Symptoms | October 2014 | December 2016 |
| NCT02270242 | Completed | Phase 4 | Ticagrelor With Aspirin or Alone in High-Risk Patients After Coronary Intervention | July 2015 | July 10, 2019 |
| NCT02285738 | Completed | Early Phase 1 | Anti-Platelet and Statin Therapy to Prevent Cancer-Associated Thrombosis | December 30, 2014 | October 1, 2018 |
| NCT00110448 | Completed | Phase 4 | Japanese Primary Prevention of Atherosclerosis With Aspirin for Diabetes (JPAD) Trial | December 2002 | April 2008 |
| NCT02294643 | Completed | Phase 3 | Study Design of 'Influence of Sarpogrelate in Patients With Renal Impairment or Diabetes Mellitus' Study | April 2009 | March 2014 |
| NCT02301780 | Completed | Phase 3 | Combined Multi-marker Screening and Treatment With Aspirin for Pre-eclampsia Prevention | December 2015 | October 2016 |
| NCT03927313 | Completed | Phase 2 | Linezolid, Aspirin and Enhanced Dose Rifampicin in HIV-TBM | June 12, 2019 | March 31, 2021 |
| NCT00122447 | Completed | N/A | Cardiovascular Disease (CVD) Risk and Prevention in Early Glucose Intolerance | May 2005 | May 2011 |
| NCT02341638 | Completed | Phase 1 | Single and Multiple Ascending Dose Study to Evaluate the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of BMS-986141 in Healthy Subjects | September 2014 | September 2015 |
| NCT02348203 | Completed | Phase 2 | Aspirin and Zileuton and Biomarker Expression in Nasal Tissue of Current Smokers | January 13, 2016 | March 9, 2021 |
| NCT00129038 | Completed | Phase 4 | Modified-release Dipyridamole/Aspirin (200mg/25mg bd) Versus Aspirin (75mg) in Aspirin-resistant Patients | April 2004 | |
| NCT02370680 | Completed | Phase 1 | Length of Effect of Extended Release Aspirin on Platelets in Patients With Diabetes and Heart Disease | February 2015 | July 2015 |
| NCT02384070 | Completed | N/A | Simplified Anti-Thrombotic Therapy for FFR | January 2009 | December 2014 |
| NCT00129805 | Completed | Phase 3 | Sarpogrelate-Aspirin Comparative Clinical Study for Efficacy and Safety in Secondary Prevention of Cerebral Infarction (S-ACCESS) | January 2001 | September 2004 |
| NCT02401269 | Completed | Phase 1/Phase 2 | Cardiovascular Risk in HIV Patients on Antiretroviral Therapy Therapy: The MHEART Study | April 2015 | January 2016 |
| NCT04645550 | Completed | Phase 4 | Apixaban, Warfarin and Aspirin Prevents Portal Vein Thrombosis in Patients After Laparoscopic Splenectomy（ESAWAAPT） | November 22, 2020 | March 31, 2023 |
| NCT00152724 | Completed | Mechanisms of Human Cutaneous Microcirculation in Healthy Volunteers | January 1996 | November 2008 | |
| NCT00175838 | Completed | N/A | Primary Thrombocythaemia 1 Trial | July 1997 | November 2016 |
| NCT02427126 | Completed | Phase 3 | Apixaban for Treatment of Embolic Stroke of Undetermined Source | December 2015 | September 2021 |
| NCT04534218 | Completed | Phase 2 | Regorafenib in Combination With Metronomic Chemotherapies, and Low-dose Aspirin in Metastatic Colorectal Cancer | October 16, 2020 | December 13, 2023 |
| NCT02439190 | Completed | Phase 1 | CV004-007 Thrombosis Chamber Study | September 2015 | March 2016 |
| NCT02531165 | Completed | N/A | Platelet Inhibition After Pre-hospital Ticagrelor Using Fentanyl Compared to Morphine in Patients With ST-segment Elevation Myocardial Infarction Undergoing Primary Percutaneous Coronary Intervention | September 2015 | February 6, 2018 |
| NCT02545933 | Completed | Phase 4 | Vorapaxar in Patients With Prior Myocardial Infarction Treated With Prasugrel and Ticagrelor | February 2016 | January 2020 |
| NCT02548650 | Completed | Phase 4 | Vorapaxar as an Add-On Antiplatelet Therapy in Patients With and Without Diabetes Mellitus | March 25, 2016 | February 14, 2019 |
| NCT02559414 | Completed | Phase 2 | Antiplatelet Therapy in HIV | February 2015 | February 2017 |
| NCT02565693 | Completed | Phase 2 | Apixaban After Anticoagulation-associated Intracerebral Haemorrhage in Patients With Atrial Fibrillation | September 2014 | January 31, 2021 |
| NCT02578706 | Completed | Phase 2 | Targeting Platelets in Chronic HIV Infection | October 2015 | November 2016 |
| NCT02607436 | Completed | Phase 4 | Effect of Sarpogrelate, a Serotonin Receptor Antagonist, on Coronary Artery Disease | July 2015 | April 2016 |
| NCT02616497 | Completed | Phase 4 | ASpirin vs Triflusal for Event Reduction In Atherothrombosis Secondary Prevention (ASTERIAS) | September 2015 | March 28, 2018 |
| NCT02630862 | Completed | N/A | Oxidative Stress and Oxysterols Profiling in Patients With Carotid Revascularization | September 2010 | December 2014 |
| NCT02640794 | Completed | Phase 4 | Aspirin Versus Aspirin+Clopidogrel as Antithrombotic Treatment Following TAVI | January 2015 | March 2018 |
| NCT02641080 | Completed | N/A | Evaluating the Need for Pneumatic Compression Devices | January 2016 | October 2016 |
| NCT02666742 | Completed | Phase 4 | DOACs for Stroke Prevention Post Ventricular Tachycardia Ablation | February 16, 2017 | April 30, 2021 |
| NCT02670304 | Completed | Phase 4 | Preventive Application of Letrozole Decrease Incidence of Early Onset of OHSS | January 2012 | August 2013 |
| NCT02671461 | Completed | Phase 2 | Safety and Efficacy Study of a Protease Activated Receptor-4 Antagonist Being Tested to Reduce the Chances of Having Additional Strokes or "Mini Strokes" | April 25, 2016 | March 31, 2017 |
| NCT00178464 | Completed | Phase 1 | Aspirin Prophylaxis in Sickle Cell Disease | March 2005 | November 2009 |
| NCT02675205 | Completed | Phase 3 | Ticagrelor vs Clopidogrel for Platelet Inhibition in Stenting for Cerebral Aneurysm | December 2015 | December 2020 |
| NCT02677545 | Completed | Phase 2 | Ticagrelor Versus Clopidogrel in Carotid Artery Stenting | December 2016 | April 28, 2022 |
| NCT02685748 | Completed | Phase 2/Phase 3 | Aspirin in Young Psychotic Patients | July 20, 2017 | December 31, 2019 |
| NCT04352439 | Completed | Phase 4 | Aspirin for Prevention of Venous Thromboembolism Among Ovarian Cancer Patients Receiving Neoadjuvant Chemotherapy | August 8, 2020 | March 2, 2022 |
| NCT02697916 | Completed | N/A | Aspirin Dosing: A Patient-Centric Trial Assessing Benefits and Long-term | April 2016 | June 30, 2020 |
| NCT02741817 | Completed | Phase 4 | WilL LOWer Dose Aspirin be More Effective Following ACS? (WILLOW-ACS) | June 26, 2016 | April 7, 2017 |
| NCT02744716 | Completed | N/A | Effects of Aspirin on Uterine Endometrial Repair Severe Intrauterine Adhesion | May 2011 | January 2016 |
| NCT04328883 | Completed | Phase 1 | Pharmacodynamics and Pharmacokinetics of Aspirin Inhalation Powder With Non-Enteric-Coated Chewable Aspirin | July 16, 2019 | October 10, 2019 |
| NCT00000151 | Completed | Phase 3 | Early Treatment Diabetic Retinopathy Study (ETDRS) | December 1979 | |
| NCT02748330 | Completed | Phase 4 | Platelet Inhibition of Ticagrelor Versus Clopidogrel in Type 2 Diabetic Patients After Elective Percutaneous Coronary Intervention | June 2016 | December 2018 |
| NCT04324463 | Completed | Phase 3 | Anti-Coronavirus Therapies to Prevent Progression of Coronavirus Disease 2019 (COVID-19) Trial | April 21, 2020 | December 30, 2022 |
| NCT02761486 | Completed | Phase 1 | Effect of Aspirin on Gut Microbiome | August 2016 | August 29, 2018 |
| NCT02776540 | Completed | Phase 4 | Clopidogrel for Acute Ischaemia of Recent Onset | June 1, 2016 | February 1, 2019 |
| NCT00189618 | Completed | Phase 4 | The Effects of Physical Training, ASA (Aspirin), and Clopidogrel on the Walking Capacity of Patients With Stage II Peripheral Arterial Disease (PAD) | May 2005 | June 2008 |
| NCT02797249 | Completed | Phase 3 | Low Dose Aspirin in the Prevention of Preeclampsia in China | December 7, 2016 | March 30, 2019 |
| NCT02823743 | Completed | N/A | RECAB-ASA; Treatment of Recurrent Abortion With Aspirin | March 2008 | June 2016 |
| NCT02824523 | Completed | Role of Inflammatory Mediators in AERD | July 2016 | May 1, 2021 | |
| NCT02848339 | Completed | Aspirin Desensitization Registry in Patients With Aspirin Hypersensitivity | May 2010 | February 2015 | |
| NCT02869009 | Completed | Phase 3 | Antiplatelet Therapy in Acute Mild-Moderate Ischemic Stroke | November 2016 | October 31, 2022 |
| NCT02878772 | Completed | Phase 2/Phase 3 | Vinpocetine Inhibits NF-κB-dependent Inflammation in Acute Ischemic Stroke Patients | May 2014 | December 2015 |
| NCT02906761 | Completed | Phase 3 | Aspirin for Uncontrolled Asthma | January 15, 2019 | June 17, 2021 |
| NCT02922673 | Completed | N/A | The Effects of Acetylsalicylic Acid on Immunoparalysis Following Human Endotoxemia | September 2016 | September 2017 |
| NCT00222261 | Completed | Phase 4 | Aspirin Non-responsiveness and Clopidogrel Endpoint Trial. | April 2003 | July 2010 |
| NCT04040465 | Completed | Early Phase 1 | Asprin Dosing Estimator in Healthy Adults | February 15, 2021 | October 30, 2021 |
| NCT04012268 | Completed | N/A | The Safety and Efficacy of RIC on Adult Moyamoya Disease | July 15, 2019 | February 2, 2021 |
| NCT04008979 | Completed | Phase 1 | Pharmacokinetic and Pharmacodynamic Assessment of a Novel, Pharmaceutical Lipid-Aspirin Complex | February 11, 2008 | June 10, 2008 |
| NCT04006288 | Completed | Phase 4 | Switching From DAPT to Dual Pathway Inhibition With Low-dose Rivaroxaban in Adjunct to Aspirin in Patients With Coronary Artery Disease | September 6, 2019 | May 16, 2022 |
| NCT03008915 | Completed | Phase 2 | Targeting Pulmonary Perfusion in Alpha-1 Antitrypsin Deficiency | January 2017 | October 2020 |
| NCT03023020 | Completed | N/A | Management of High Bleeding Risk Patients Post Bioresorbable Polymer Coated Stent Implantation With an Abbreviated Versus Prolonged DAPT Regimen | April 4, 2017 | April 30, 2021 |
| NCT03038607 | Completed | Phase 2 | Aspirin in Asymmetrically Intrauterine Growth | January 2016 | January 2017 |
| NCT03396952 | Completed | Phase 2 | Prostaglandin Inhibition and Immune Checkpoint Blockade in Melanoma | April 19, 2018 | June 30, 2022 |
| NCT03456960 | Completed | Phase 1 | A Study to Evaluate the Bioequivalence (BE) and the Food Effect of TAK-438ASA Tablet | March 8, 2018 | October 12, 2018 |
| NCT03487406 | Completed | Phase 2 | Anti-platelet Therapy in the Prevention of Cardiovascular Disease in Patients With COPD (APPLE-COPD: ICON 2) | September 2015 | November 2017 |
| NCT03698513 | Completed | Phase 1 | A Study to Assess Administration of an Oral Anti-thrombotic With Antiplatelet Therapy in Healthy Subjects | October 4, 2018 | February 19, 2019 |
| NCT03661411 | Completed | Phase 4 | Antiplatelet vs R-tPA for Acute Mild Ischemic Stroke | October 17, 2018 | July 18, 2022 |
| NCT03581409 | Completed | Phase 4 | Comparison of Two Different Antiplatelet Preparations for an Unruptured Intracranial Aneurysm | October 24, 2018 | January 22, 2021 |
| NCT03578822 | Completed | Phase 3 | Thrombolysis With rhPro-UK in 4.5-6 Hours After Acute Ischemic Stroke in a Double-blinded,Controlled Trial | August 10, 2018 | March 1, 2020 |
| NCT00234299 | Completed | N/A | Effects of ASA on Prostate Tissue | December 2005 | December 2015 |
| NCT00244426 | Completed | Phase 3 | S.I.F.A. II: Prevention Of Thromboembolic Events In Patients With Nonrheumatic Atrial Fibrillation | December 2000 | April 2008 |
| NCT00258245 | Completed | Phase 1 | Arsenic Trioxide and Ascorbic Acid Combined With Bortezomib, Thalidomide, and Dexamethasone in Treating Patients With Relapsed or Refractory Multiple Myeloma or Plasma Cell Leukemia | May 2005 | April 2008 |
| NCT00262561 | Completed | Phase 4 | Resistance to Aspirin and/or Clopidogrel Among Patients With PAD. | January 2006 | January 2008 |
| NCT00000469 | Completed | Phase 2 | Asymptomatic Carotid Artery Plaque Study (ACAPS) | May 1988 | August 1998 |
| NCT00272311 | Completed | Phase 4 | Aspirin Dose and Atherosclerosis in Patients With Metabolic Syndrome | October 2006 | January 2009 |
| NCT00272324 | Completed | Phase 2/Phase 3 | Aspirin/Folate Prevention of Large Bowel Polyps | February 1992 | January 2007 |
| NCT00272337 | Completed | Phase 4 | Aspirin Dose and Atherosclerosis in Patients With Heart Disease | October 2006 | June 2009 |
| NCT00272454 | Completed | Phase 4 | Cilostazol in Acute Ischemic Stroke Treatment (CAIST) | January 2006 | September 2008 |
| NCT00300365 | Completed | Phase 2 | Pioglitazone vs Placebo in Combination With Niacin Extended Release on Low HDL | November 2005 | August 2010 |
| NCT00330772 | Completed | Phase 3 | Preoperative Aspirin and Postoperative Antiplatelets in Coronary Artery Bypass Grafting: The PAPA CABG Study | July 2006 | December 2008 |
| NCT00343876 | Completed | Phase 4 | Clopidogrel and Aspirin Together: The Effect on C-Reactive Protein Trial | July 2005 | November 2006 |
| NCT00371501 | Completed | Phase 4 | Aspirin and Statins for Prevention of Atherosclerosis and Arterial Thromboembolism in Systemic Lupus Erythematosus | June 2006 | December 2009 |
| NCT00000479 | Completed | Phase 3 | Women's Health Study (WHS): A Randomized Trial of Low-dose Aspirin and Vitamin E in the Primary Prevention of Cardiovascular Disease and Cancer | September 1992 | February 2005 |
| NCT00405613 | Completed | Phase 2 | Aspirin Use and Postoperative Bleeding From Dental Extractions in a Healthy Population | May 2003 | December 2005 |
| NCT00405756 | Completed | Phase 3 | A Study to Compare MPR With MP in Newly Diagnosed Multiple Myeloma Subjects 65 Years Old or Older. | January 2007 | April 2016 |
| NCT00406991 | Completed | Phase 2 | Retinal Blood Flow and Microthrombi in Type 1 Diabetes | June 2003 | March 2006 |
| NCT00441519 | Completed | Phase 1 | A Parallel Group Study to Compare the Gastroprotective Effects of PA 325 Versus 81 mg Enteric Coated Aspirin | February 2007 | April 2007 |
| NCT00442052 | Completed | Phase 1 | To Compare the Gastroprotective Effects and Pharmacokinetic Profile of PA Versus Enteric-Coated Aspirin | November 2006 | January 2007 |
| NCT00443794 | Completed | N/A | The Indian POLYCAP Study (TIPS) | March 2007 | October 2008 |
| NCT00466154 | Completed | N/A | The Effect of Serum LDL Lowering on Aspirin Resistance | July 2005 | January 2007 |
| NCT00470561 | Completed | N/A | Effect of Aspirin on Mammogram Density in Healthy Postmenopausal Women With a Moderate or High Level of Breast Density | November 2005 | July 2007 |
| NCT00479362 | Completed | Phase 4 | Anticoagulant Therapy During Pacemaker Implantation | September 2005 | September 2012 |
| NCT00000491 | Completed | Phase 3 | Aspirin-Myocardial Infarction Study (AMIS) | October 1974 | August 1979 |
| NCT00535925 | Completed | Phase 4 | Nephropathy In Type 2 Diabetes and Cardio-renal Events | October 2005 | May 2019 |
| NCT00548678 | Completed | Phase 1 | Platelet Function and Safety After IV and Oral Diclofenac, IV Ketorolac and Oral Aspirin in Adult Volunteers | October 2007 | November 2007 |
| NCT00562289 | Completed | Phase 3 | Patent Foramen Ovale Closure or Anticoagulants Versus Antiplatelet Therapy to Prevent Stroke Recurrence | December 2007 | December 2016 |
| NCT00568152 | Completed | N/A | Effect of Apple Flavanols on Risk of Cardiovascular Disease | May 2006 | May 2008 |
| NCT00578721 | Completed | Phase 2 | Trial of Aspirin and Arginine Restriction in Colorectal Cancer | September 24, 2008 | November 26, 2013 |
| NCT00590174 | Completed | Phase 4 | Clopidogrel Use and Long-term Safety After Drug-Eluting Stents Implantation | October 2007 | April 2010 |
| NCT00619073 | Completed | N/A | PACT (Platelet Activity After Clopidogrel Termination) | April 2008 | May 2009 |
| NCT00623779 | Completed | Phase 2 | Atrial Fibrillation (AF) Patients Not Taking Vitamin-K Antagonist (VKA) | October 2007 | October 2008 |
| NCT00637988 | Completed | Phase 4 | Barrett's Esophagus - 315 - 3 Way Cross Over | April 2002 | June 2003 |
| NCT00642811 | Completed | Phase 2 | A Study of the Antiplatelet Effects Comparing Ticagrelor (Ticag. - AZD6140) With Clopidogrel (Clop.) Responder and Non-responders | May 2008 | March 2009 |
| NCT00644085 | Completed | Phase 3 | Does Low-Dose Aspirin Improve Outcome in In Vitro Fertilisation/Intra Cytoplasmatic Sperm Injection (IVF/ICSI)? | April 2000 | December 2007 |
| NCT00664040 | Completed | N/A | Heredity and Phenotype Intervention (HAPI) Heart Study | May 2003 | August 2006 |
| NCT00684203 | Completed | Phase 2 | Trial to Assess the Safety and Effects of Vorapaxar in Japanese Subjects With Acute Coronary Syndrome (P04772; MK-5348-016) | December 1, 2006 | October 1, 2007 |
| NCT00687076 | Completed | Phase 4 | Effectiveness of Intensive Lipid Modification Medication in Preventing the Progression of Peripheral Arterial Disease (The ELIMIT Study) | April 2004 | December 2010 |
| NCT00688961 | Completed | Early Phase 1 | Effects of Omacor and Aspirin on Platelet Function | June 2007 | August 2007 |
| NCT00697151 | Completed | Phase 4 | Patent Foramen Ovale in Cryptogenic Stroke Study | June 1993 | June 2000 |
| NCT00000496 | Completed | Phase 3 | Platelet Drug Trial in Coronary Disease Progression | December 1979 | December 1982 |
| NCT05994287 | Completed | N/A | Pain Treatment With Combinations of NSAIDs | January 1, 2021 | January 1, 2023 |
| NCT00727948 | Completed | Early Phase 1 | The Effect of Aspirin on Angiogenesis Proteins in Women on Tamoxifen Therapy | July 2008 | December 2012 |
| NCT00000500 | Completed | Phase 3 | Physicians' Health Study | September 1981 | December 1996 |
| NCT00741286 | Completed | Phase 4 | Effect of Cilostazol in the Acute Lacunar Infarction Based on Pulsatility Index of Transcranial Doppler | November 2006 | October 2008 |
| NCT00000510 | Completed | Phase 3 | Platelet-Inhibitor Drug Trial in Coronary Angioplasty | September 1983 | September 1988 |
| NCT00000520 | Completed | Phase 2 | Prevention of Coronary Aneurysms in Kawasaki Syndrome | July 1985 | November 1989 |
| NCT00771914 | Completed | Phase 1/Phase 2 | The Effects of Omega-3 Fatty Acids on Aspirin Resistance | November 2008 | January 2009 |
| NCT00778193 | Completed | Phase 4 | Effect of Naproxen, Aspirin, Celecoxib, or Clopidogrel on the Healing of Stomach and Intestinal Ulcers | October 2007 | March 2008 |
| NCT00000527 | Completed | Phase 2 | Recurrent Carotid Stenosis | August 1986 | November 1998 |
| NCT00793754 | Completed | Phase 4 | Aspirin Statins Or Both For The Reduction Of Thrombin Generation In Diabetic People | March 2009 | October 2011 |
| NCT00797056 | Completed | Early Phase 1 | Stem Cell Mobilization by G-CSF to Treat Severe Peripheral Artery Disease | April 2008 | April 2012 |
| NCT00799396 | Completed | Phase 4 | Determining Genetic Role in Treatment Response to Anti-Platelet Interventions (The PAPI Study) | July 2006 | February 2012 |
| NCT00812032 | Completed | Phase 4 | Evaluation of Antiplatelet Effects of Different Dosages of Aspirin in Type 2 Diabetic Patients | January 2008 | October 2010 |
| NCT00814268 | Completed | Phase 4 | COMbination of Clopidogrel and Aspirin for Prevention of Early REcurrence in Acute Atherothrombotic Stroke | December 2008 | May 2012 |
| NCT00818337 | Completed | Phase 4 | Aspirin Responsiveness in Women at Risk for Cardiac Events | November 2008 | June 2009 |
| NCT00822536 | Completed | Phase 4 | Optimal Duration of Dual Antiplatelet Therapy After Drug-eluting Stent Implantation | January 2009 | September 2014 |
| NCT00823212 | Completed | Phase 3 | The PLATINUM Clinical Trial to Assess the PROMUS Element Stent System for Treatment of De Novo Coronary Artery Lesions | January 2009 | December 2014 |
| NCT00827411 | Completed | Phase 4 | Double Randomization of a Monitoring Adjusted Antiplatelet Treatment Versus a Common Antiplatelet Treatment for DES Implantation, and Interruption Versus Continuation of Double Antiplatelet Therapy | January 2009 | January 2013 |
| NCT00833833 | Completed | Phase 1/Phase 2 | MTD, Safety, and Efficacy of Pomalidomide (CC-4047) Alone or With Low-dose Dexamethasone in Patients With Relapsed and Refractory Multiple Myeloma | June 2008 | September 2015 |
| NCT00847860 | Completed | Phase 4 | Cilostazol Verse Asprin for Vascular Dementia in Poststroke Patients With White Matter Lesions | March 2008 | June 2011 |
| NCT00858715 | Completed | N/A | Resistance to Antithrombotic Therapy | May 2008 | May 2012 |
| NCT00861341 | Completed | Phase 2 | Effects of Pioglitazone on Platelet Function | December 2008 | June 2011 |
| NCT00882388 | Completed | Phase 4 | The Effect of Celecoxib on the Antiplatelet Effect of Aspirin and Clopidogrel in Normal Volunteers | March 2005 | June 2005 |
| NCT00898222 | Completed | N/A | Effect of Daily Low Dose Aspirin on Exhaled Inflammatory Mediators in Normal Subjects | May 2009 | August 2009 |
| NCT00898950 | Completed | N/A | Effects of Different Doses of Aspirin on Pathophysiological Markers in Type 2 Diabetes | August 2004 | July 2006 |
| NCT00935506 | Completed | Phase 1 | Ex Vivo Human Thrombosis Chamber Study | July 2009 | October 2009 |
| NCT00002527 | Completed | Phase 3 | Aspirin in Treating Patients With Colorectal Cancer That Has Been Surgically Removed | May 1993 | January 2006 |
| NCT00948987 | Completed | Phase 1 | Mechanism Based Resistance to Aspirin | September 2004 | October 2009 |
| NCT00959621 | Completed | Phase 3 | Low Molecular Weight Heparin and/or Aspirin in Prevention of Habitual Abortion | January 2002 | December 2008 |
| NCT00983580 | Completed | Phase 2 | Acetylsalicylic Acid and Eflornithine in Treating Patients at High Risk for Colorectal Cancer | August 20, 2009 | August 13, 2019 |
| NCT00997503 | Completed | TAXUS Libertē Post Approval Study | December 2009 | July 2015 | |
| NCT01042704 | Completed | Phase 1 | Bendamustine in Combination With Lenalidomide and Dexamethasone in Refractory or Relapsed Multiple Myeloma | February 2008 | March 2015 |
| NCT01096706 | Completed | N/A | Effects of Urocortins on Forearm Arterial Blood Flow in Healthy Volunteers (Protocol 3) | July 2011 | January 2012 |
| NCT01102439 | Completed | Phase 4 | Clopidogrel/Aspirin Interaction Study | April 2010 | February 2013 |
| NCT01108588 | Completed | Phase 1 | Reproducibility and Comparison of Platelet Function Assays With Aspirin and Clopidogrel (MK-0000-167) | June 2010 | August 2010 |
| NCT00004727 | Completed | Phase 4 | Antiplatelet Therapy to Prevent Stroke in African Americans | ||
| NCT01188304 | Completed | Phase 1 | A Study of Aleglitazar in Combination With Aspirin in Healthy Volunteers | July 2010 | October 2010 |
| NCT01192724 | Completed | Phase 4 | Additional Benefit of Cilostazol to Dual Antiplatelet Therapy After Biolimus-eluting Stent Implantation | March 2010 | December 2012 |
| NCT01199328 | Completed | Phase 1 | Study to Evaluate the Interaction Between Aspirin and Nexium | September 2010 | November 2010 |
| NCT01201785 | Completed | Phase 4 | Aspirin Dosing in Diabetic Patients | January 2009 | September 2010 |
| NCT01259817 | Completed | Phase 2 | Pegylated Interferon Alfa-2a Salvage Therapy in High Risk Polycythemia Vera (PV) or Essential Thrombocythemia (ET) | September 2011 | December 2016 |
| NCT01259856 | Completed | Phase 3 | Randomized Trial of Pegylated Interferon Alfa-2a Versus Hydroxyurea in Polycythemia Vera (PV) and Essential Thrombocythemia (ET) | September 2011 | June 30, 2017 |
| NCT05604118 | Completed | N/A | Platelet Enzymatically Oxidized Phospholipids (eoxPL) Characterisation in a Healthy Cohort on and Off Aspirin | August 1, 2016 | June 1, 2022 |
| NCT01275300 | Completed | N/A | Biosynthesis of PGD2 in Vivo | July 2007 | January 2012 |
| NCT01281111 | Completed | Phase 1 | Alternate Dosing Regimens of BG00012 in Healthy Volunteers | February 1, 2011 | March 18, 2011 |
| NCT01341964 | Completed | Phase 4 | Clopidogrel and Aspirin Interaction Study-2 | May 2011 | April 2013 |
| NCT01353144 | Completed | Phase 4 | A Comparison of Two Therapeutic Strategies for the Treatment of Aspirin-associated Peptic Ulcers | June 2007 | May 2008 |
| NCT01355705 | Completed | Phase 1/Phase 2 | Phase 1-2 Amrubicin in Combo With Lenalidomide + Weekly Dexamethasone in Relapsed/Refractory Multiple Myeloma | August 2011 | July 2017 |
| NCT01361620 | Completed | N/A | Genotypic and Phenotypic Correlates of Resistance to Aspirin | December 2007 | April 2011 |
| NCT01374698 | Completed | Phase 4 | Aspirin Reload Before Percutaneous Coronary Intervention: Reperfusion Indexes Evaluation. | January 2011 | September 2012 |
| NCT01397513 | Completed | Phase 4 | Effects of Aspirin Treatment on Fibrin Network Formation in Patients With Type 1 Diabetes | March 2006 | February 2011 |
| NCT01426438 | Completed | Phase 2 | Endothelial Function, Lipoproteins, and Inflammation With Low HDL Cholesterol in HIV: ER Niacin Versus Fenofibrate | November 2011 | October 2013 |
| NCT01429272 | Completed | Phase 3 | Minocycline and Aspirin in the Treatment of Bipolar Depression | September 2011 | September 2015 |
| NCT05546957 | Completed | N/A | Assess Gastrointestinal Blood Loss After Receiving Aspirin or Aspirin Plus Rivaroxaban in Healthy Adult Participants | January 5, 2023 | April 6, 2023 |
| NCT01438580 | Completed | Phase 4 | The Effect and Safety of Different Intensity Anticoagulation Therapy in Elderly Patients With Non-valvular Atrial Fibrillation | January 2010 | April 2012 |
| NCT01452568 | Completed | Phase 4 | Anticoagulant After Implantation of Biological Aortic Valve Comparing With Aspirin | June 2005 | March 2012 |
| NCT01500434 | Completed | Phase 3 | The PLATINUM Clinical Trial to Assess the PROMUS Element Stent System for Treatment of Long De Novo Coronary Artery Lesions (PLATINUM LL) | February 2009 | May 2015 |
| NCT01504867 | Completed | Phase 2 | LIPS-A: Lung Injury Prevention Study With Aspirin | January 2012 | September 2015 |
| NCT01510327 | Completed | Phase 3 | PLATINUM Trial to Assess the PROMUS Element Stent System for Treatment of De Novo Coronary Artery Lesions-Pharmacokinetics (PLATINUM PK) | October 2009 | May 2015 |
| NCT01534026 | Completed | Phase 4 | Aspirin Withdrawal in Non-ischaemic Cardiomyopathy Study | March 2012 | February 2015 |
| NCT01559298 | Completed | Phase 4 | Aspirin Versus Aspirin + ClopidogRel Following Transcatheter Aortic Valve Implantation: the ARTE Trial | March 2012 | March 2016 |
| NCT01589978 | Completed | Phase 4 | PROMUS Element Plus US Post-Approval Study | May 2012 | June 2018 |
| NCT01612273 | Completed | Phase 4 | The Effect of Triflusal on Peripheral Microcirculation Dysfunction | April 2011 | June 2013 |
| NCT01616615 | Completed | Phase 2 | Aspirin for the Enhancement of Trophoblastic Invasion in Women With Abnormal Uterine Artery Doppler at 11-14 Weeks of Gestation | September 2012 | April 2015 |
| NCT01618006 | Completed | Phase 2 | Multiple Daily Doses Of Aspirin To Overcome Aspirin Hyporesponsiveness Post Cardiac Bypass Surgery | January 2012 | August 2013 |
| NCT01646437 | Completed | Phase 3 | The International Polycap Study 3 (TIPS-3) | June 2012 | August 30, 2021 |
| NCT01663038 | Completed | Phase 1 | Comparative Pharmacokinetics Study of Clopidogrel and Aspirin Fixed-dose Combination Versus Separate Combination | December 2010 | September 2011 |
| NCT05304845 | Completed | Phase 1 | Drug-drug Interactions Between DWP14012 and Aspirin in Healthy Subjects | March 21, 2022 | May 22, 2022 |
| NCT01675115 | Completed | Phase 3 | Efficacy of BNG-1 to Treat Acute Ischemic Stroke | August 2012 | November 2014 |
| NCT01708369 | Completed | Phase 1 | Alcohol Inhibits Drug Metabolism by Carboxylesterases | February 2012 | May 2012 |
| NCT05278637 | Completed | Early Phase 1 | GM03 - Platelet RNA Signatures of Aspirin | November 1, 2013 | December 5, 2016 |
| NCT01710072 | Completed | Phase 1 | Aspirin Attenuates Inflammation in Human Cerebral Aneurysms | August 2011 | August 2014 |
| NCT01729468 | Completed | Phase 4 | Prevention of Pre-eclampsia and SGA by Low-Dose Aspirin in Nulliparous Women With Abnormal First-trimester Uterine Artery Dopplers | June 27, 2012 | October 25, 2016 |
| NCT01733485 | Completed | Phase 1 | Electrophilic Fatty Acid Derivatives in Asthma | October 2011 | June 2017 |
| NCT01740921 | Completed | N/A | GLP-1 and Microvascular Function in Type 2 Diabetes | January 2011 | February 2016 |
| NCT00007683 | Completed | Phase 3 | Warfarin and Antiplatelet Therapy in Chronic Heart Failure | October 1998 | December 2004 |
| NCT01758614 | Completed | Phase 3 | The Carotid and Middle Cerebral Artery Occlusion Surgery Study | June 6, 2013 | March 1, 2020 |
| NCT01762787 | Completed | Phase 1 | Phase I Methodology Study to Validate the Cantharidin Blister Model in Healthy Volunteers | August 17, 2010 | January 14, 2011 |
| NCT01763606 | Completed | N/A | Enoxaparin Versus Aspirin in Patients With Cancer and Stroke | December 18, 2012 | April 3, 2019 |
| NCT01768637 | Completed | Phase 1 | Whole Blood Platelet Aggregation in Chronic Kidney Disease Patients on Aspirin Study | January 2013 | June 2014 |
| NCT01776424 | Completed | Phase 3 | Rivaroxaban for the Prevention of Major Cardiovascular Events in Coronary or Peripheral Artery Disease | February 28, 2013 | June 15, 2021 |
| NCT00041938 | Completed | Phase 3 | Warfarin Versus Aspirin in Reduced Cardiac Ejection Fraction (WARCEF) Trial | October 2002 | July 2014 |
| NCT01790997 | Completed | Phase 3 | Efficacy of DLBS1033 in Patients With Acute Ischemic Stroke | May 2012 | December 2013 |
| NCT01797575 | Completed | Phase 2 | N-Acetyl Cysteine and Aspirin as an Adjunctive Treatment for Bipolar Disorder | January 2013 | February 1, 2017 |
| NCT01802775 | Completed | Phase 2 | Edoxaban in Peripheral Arterial Disease | February 6, 2013 | December 3, 2014 |
| NCT01809054 | Completed | Phase 4 | Pilot Study Evaluating Alterations in Thrombogenicity and Platelet Reactivity Following Lower Extremity Arthroplasty | April 2012 | February 2013 |
| NCT01815008 | Completed | Phase 4 | Pharmacogenomics of Antiplatelet Response - I | October 2012 | June 2014 |
| NCT01817400 | Completed | Early Phase 1 | Mediators of Abnormal Reproductive Function in Obesity (MARO) | March 2013 | December 2014 |
| NCT01831011 | Completed | Phase 2 | Mildronate for Acute Ischemic Stroke | July 2008 | April 2010 |
| NCT01867281 | Completed | Phase 4 | The Effect of Aspirin Desensitization on Patients With Aspirin-exacerbated Respiratory Diseases | June 2013 | June 2014 |
| NCT05093790 | Completed | Phase 2 | A Study to Evaluate BMS-986141 Added on to Aspirin or Ticagrelor or the Combination, on Thrombus Formation in a Thrombosis Chamber Model in Participants With Stable Coronary Artery Disease and Healthy Participants | March 25, 2022 | November 14, 2022 |
| NCT01887704 | Completed | N/A | Effect of Rotablator on Balloon Resistant Calcified Coronary Lesion | January 2010 | May 2013 |
| NCT01894555 | Completed | Phase 4 | Pharmacogenomics of Antiplatelet Response - II (PARes-II) | January 2013 | August 2014 |
| NCT01902498 | Completed | Phase 2 | Multiple Daily Doses of Aspirin to Overcome Hyporesponsiveness Post Cardiac Bypass Surgery (ASACABG)- Part B | July 2013 | July 2014 |
| NCT04949516 | Completed | Phase 4 | Mono Antiplatelet and Colchicine Therapy | June 15, 2021 | December 31, 2022 |
| NCT04888377 | Completed | ASPIRIN: Neurodevelopmental Follow-up Trial | September 1, 2021 | June 15, 2022 | |
| NCT01938248 | Completed | Phase 4 | Apixaban for the Reduction of Thrombo-Embolism in Patients With Device-Detected Sub-Clinical Atrial Fibrillation | May 2015 | November 3, 2023 |
| NCT00054938 | Completed | Phase 2 | Prevention of Atherosclerosis and Heart Disease in Patients With Systemic Lupus Erythematosis (SLE) | March 2003 | December 2005 |
| NCT01976806 | Completed | Phase 2 | The Effects of DHA on Periodontitis | June 2009 | September 2011 |
| NCT01995370 | Completed | Phase 4 | Cilostazol Stroke Prevention Study for Antiplatelet Combination | December 13, 2013 | December 7, 2018 |
| NCT02008981 | Completed | Phase 3 | Effect of Herbal Products on Platelet Function and Clotting | December 2013 | April 2014 |
| NCT00059306 | Completed | Phase 3 | Secondary Prevention of Small Subcortical Strokes Trial | February 2003 | April 2012 |
| NCT02044250 | Completed | Phase 4 | Harmonizing Optimal Strategy for Treatment of Coronary Artery Stenosis- EXtended Antiplatelet Monotherapy (HOST-EXAM) | February 2014 | March 2021 |
| NCT00061373 | Completed | Phase 2 | Combination Anti-Platelet and Anti-Coagulation Treatment After Lysis of Ischemic Stroke Trial (CATALIST) | May 2003 | July 2011 |
| NCT02049762 | Completed | Phase 4 | Aspirin Impact on Platelet Reactivity in Acute Coronary Syndrome Patients on Novel P2Y12 Inhibitors Therapy | June 2015 | January 2017 |
| NCT02053909 | Completed | Phase 4 | Ticagrelor Antiplatelet Therapy to Reduce Graft Events and Thrombosis | September 2014 | August 2021 |
| NCT02062255 | Completed | Early Phase 1 | Impact of COX2 on Sera Biomarkers From Obese Subjects | October 2013 | April 2016 |
| NCT02071004 | Completed | Phase 1 | DS1040b/Aspirin Drug/Drug Interaction Study | January 2014 | February 2014 |
| NCT00105209 | Completed | Phase 2 | A Study of Aspirin and Clopidogrel in Patients With Idiopathic Pulmonary Arterial Hypertension | April 2002 | December 2003 |
| NCT02081638 | Completed | Phase 2 | Elite Controller and ART-treated HIV+ Statin Versus ASA Treatment Intervention Study | April 18, 2014 | October 16, 2019 |
| NCT02102828 | Completed | N/A | Multimodal DVT Protocol in Tourniquet-less Total Knee Arthroplasty | March 2014 | March 2015 |
| NCT02123849 | Completed | Phase 2 | Intermittent or Continuous Acetylsalicylic Acid and Gene Expression in the Nasal Tissue of Current Smokers | June 2014 | February 2018 |
| NCT02155985 | Completed | Phase 2 | Modulation of Immune Activation by Aspirin | August 2014 | July 2015 |
| NCT02158806 | Completed | Phase 3 | Low Dose Aspirin for Venous Leg Ulcers | March 2015 | March 31, 2017 |
| NCT02164578 | Completed | Phase 3 | Microvascular and Antiinflammatory Effects of Rivaroxaban Compared to Aspirin in Type-2 Diabetic Patients With Subclinical Inflammation and High Cardiovascular Risk | April 2015 | April 30, 2020 |
| NCT02164864 | Completed | Phase 3 | Evaluation of Dual Therapy With Dabigatran vs. Triple Therapy With Warfarin in Patients With AF That Undergo a PCI With Stenting (REDUAL-PCI) | July 22, 2014 | June 5, 2017 |
| NCT02169271 | Completed | Phase 2 | Acetylsalicylic Acid Compared to Placebo in Treating High-Risk Patients With Subsolid Lung Nodules | November 21, 2014 | February 14, 2020 |
| NCT02187562 | Completed | Phase 1 | Effect of Steady State Meloxicam on Low Dose Aspirin Induced Inhibition of Platelet Aggregation and Thromboxane Synthesis in Healthy Males and Females | July 2002 | |
| NCT02201771 | Completed | Phase 4 | Different Antiplatelet Therapy Strategy After Coronary Artery Bypass Graft Surgery | July 2014 | January 2017 |
| NCT02219412 | Completed | Phase 4 | Arachidonic Acid-induced Platelet Aggregation Rate in Patients With Stable CAD Treated With Ticagrelor Monotherapy | August 2014 | August 2015 |
| NCT00109382 | Completed | Phase 2/Phase 3 | Fast Assessment of Stroke and Transient Ischemic Attack to Prevent Early Recurrence (FASTER) | May 2003 | February 2007 |
| NCT02234427 | Completed | Phase 4 | Pharmacogenomics of Antiplatelet Response | June 2014 | May 2015 |
| NCT02247414 | Completed | Phase 4 | Warfarin Prevents Portal Vein Thrombosis in Patients After Laparoscopic Splenectomy and Azygoportal Disconnection | September 2014 | April 2018 |
| NCT02251184 | Completed | Phase 4 | Pharmacokinetics of Dipyridamole Administered as Aggrenox® (Dipyridamole Extended Release Plus Aspirin) Capsule Versus Dipyridamole Immediate Release Plus Aspirin Following Alteration of Stomach pH | October 2000 | |
| NCT04464070 | Enrolling by invitation | Early Phase 1 | Pathways of Eicosanoid Metabolism | August 15, 2020 | August 4, 2025 |
| NCT01049633 | No longer available | B-Lymphocyte Immunotherapy in Islet Transplantation for Initial Islet Graft Failure | |||
| NCT06090890 | Not yet recruiting | Phase 4 | Anti-inflammatory Therapy for Recurrent In-stent Restenosis | October 30, 2023 | October 29, 2026 |
| NCT06088433 | Not yet recruiting | Phase 4 | Ticagrelor Single Antiplatelet Therapy in Patients With High Risk of Bleeding After DCB for Coronary Small Vessel Disease | November 15, 2023 | November 30, 2025 |
| NCT04305028 | Not yet recruiting | Influence of Rivaroxaban for Intermittent Claudication and Exercise Tolerance in Patients With Symptomatic PAD | March 10, 2021 | December 31, 2024 | |
| NCT06018688 | Not yet recruiting | Phase 2 | Osimertinib Combined With Aspirin Neoadjuvant Therapy for Resectable EGFR Mutated NSCLC Patients. | September 15, 2023 | September 1, 2026 |
| NCT03290820 | Not yet recruiting | Phase 2 | Aspirin Improve Survival of N2-3 Nasopharyngeal Carcinoma Patients | January 1, 2018 | September 30, 2024 |
| NCT06451198 | Not yet recruiting | Phase 4 | IndObufen Versus asPirin After Coronary Drug-eluting Stent implantaTION in Elderly Patients With Acute Coronary Syndrome | July 1, 2024 | May 31, 2027 |
| NCT02497820 | Not yet recruiting | Phase 3 | Finding the Best Dose of Aspirin to Prevent Lynch Syndrome Cancers | September 2016 | September 2027 |
| NCT05910125 | Not yet recruiting | Phase 4 | Aspirin Combined With Clopidogrel Versus Intravenous Alteplase for Acute Minor Stroke | July 2023 | July 2027 |
| NCT06444178 | Not yet recruiting | Phase 1 | Assessment of Gastrointestinal Blood Loss After Receiving Aspirin or Aspirin Plus Rivaroxaban, or Aspirin Plus REGN9933, or Aspirin Plus REGN7508 in Healthy Adult Participants | October 4, 2024 | July 2, 2025 |
| NCT04188119 | Not yet recruiting | Phase 2 | A Proof of Concept Window Trial of the IMmunological Effects of AveLumab and Aspirin in Triple-Negative Breast Cancer | December 1, 2023 | May 31, 2025 |
| NCT05700266 | Not yet recruiting | Phase 2/Phase 3 | Anticoagulation Using Rivaroxaban on Top of Aspirin in Intracranial Atherosclerotic Stenosis | December 30, 2023 | December 2024 |
| NCT06168461 | Recruiting | Early Phase 1 | Daily Aspirin Treatment After Preeclampsia | November 1, 2023 | February 2026 |
| NCT05056896 | Recruiting | Early Phase 1 | ASPIRED-XT: ASPirin Intervention for the REDuction of Colorectal Cancer Risk -EXTension | June 3, 2022 | December 31, 2025 |
| NCT04796714 | Recruiting | Phase 4 | AntiPlatelet theraPy stratEgy followiNg Left Atrial appenDAGe closurE | October 3, 2022 | May 3, 2024 |
| NCT06261203 | Recruiting | N/A | Low Dose Aspirin for Prevention of Early Pregnancy Loss | July 1, 2023 | July 15, 2025 |
| NCT05932472 | Recruiting | Phase 4 | Randomized Comparison of Morning Versus Bedtime Administration of Aspirin: A Cardiovascular Circadian Chronotherapy (C3) Trial | January 15, 2024 | February 15, 2027 |
| NCT05347069 | Recruiting | Phase 4 | Efficacy and Safety of Aspirin in Patients With Chronic Coronary Syndromes Without Revascularization | June 14, 2022 | December 2030 |
| NCT06133803 | Recruiting | Phase 4 | Lovenox With Aspirin in Thawed Blastocyst Transfer | January 26, 2024 | December 15, 2024 |
| NCT05036109 | Recruiting | N/A | DAILY: Vitamin D, Aspirin, ExercIse, Low Saturated Fat Foods StudY in Colorectal Cancer Patients With Minimal Residual Disease | October 12, 2021 | April 30, 2025 |
| NCT06378398 | Recruiting | Early Phase 1 | A Trial of Omeprazole and Low Dose Aspirin to Identify Colorectal Biomarkers of Preventive Efficacy | June 2024 | January 2026 |
| NCT05730621 | Recruiting | Phase 4 | A Study to Compare the Effects of Sarpogrelate Sustained Release /Aspirin Combination Therapy Versus Aspirin on Blood Viscosity in the Patients With Peripheral Arterial Disease and Coronary Artery Disease | January 11, 2023 | February 28, 2024 |
| NCT05709483 | Recruiting | Early Phase 1 | Predictors of Aspirin Failure in Preeclampsia Prevention | April 13, 2023 | November 1, 2025 |
| NCT04918524 | Recruiting | The Clinical Features and Pregnancy Outcomes of CTD Patients | September 11, 2018 | December 31, 2026 | |
| NCT06108947 | Recruiting | N/A | Screening for Preeclampsia in Norway With Aspirin Discontinuation at 24-28 Weeks | January 1, 2024 | December 2025 |
| NCT05310968 | Recruiting | Phase 4 | Study on Tirofiban With Aspirin in the Treatment of Acute Penetrating Artery Territory Infarction | November 2022 | September 2024 |
| NCT04912505 | Recruiting | Phase 2 | ASPirin in Immune thRombocytopenia Patients With Cardiovascular disEase | January 16, 2023 | September 1, 2025 |
| NCT01650792 | Recruiting | Phase 4 | Clinical Assessment, Neuroimaging and Immunomarkers in Chagas Disease Study (CLINICS) | July 2012 | June 2024 |
| NCT04770012 | Recruiting | Phase 3 | AERIAL Trial: Antiplatelet Therapy in Heart Transplantation | June 28, 2021 | December 2024 |
| NCT02735707 | Recruiting | Phase 3 | Randomized, Embedded, Multifactorial Adaptive Platform Trial for Community- Acquired Pneumonia | April 11, 2016 | February 2028 |
| NCT02735902 | Recruiting | Phase 4 | Anticoagulation Alone Versus Anticoagulation and Aspirin Following Transcatheter Aortic Valve Interventions (1:1) | June 1, 2017 | February 2024 |
| NCT04847752 | Recruiting | Study of Predictive Factors Related to Prognosis of Patients With Ischemic Stroke Due to Large-artery Atherosclerosis | March 1, 2021 | December 31, 2028 | |
| NCT04718025 | Recruiting | Phase 3 | Evaluation of Safety and Efficacy of Two Ticagrelor-based De-escalation Antiplatelet Strategies in Acute Coronary Syndrome | February 7, 2022 | June 30, 2024 |
| NCT05663307 | Recruiting | Phase 2/Phase 3 | The Effect of Ginkgolide on Clinical Improvement of Patients With Acute Ischemic Stroke | January 1, 2021 | December 1, 2023 |
| NCT04078568 | Recruiting | Phase 3 | Efficacy of Immunoglobulin Plus Prednisolone in Reducing Coronary Artery Lesion in Patients With Kawasaki Disease | January 15, 2020 | September 2025 |
| NCT03961334 | Recruiting | Phase 3 | MidregiOnal Proatrial Natriuretic Peptide to Guide SEcondary Stroke Prevention | December 5, 2019 | January 31, 2026 |
| NCT05644210 | Recruiting | Telitacicept Followed With Rituximab Therapy on APS Secondary to SLE | October 1, 2022 | December 30, 2025 | |
| NCT04295486 | Recruiting | Phase 2 | Optimal Dosing For Low-Dose Aspirin Chemoprophylaxis For VTE Following Total Joint Arthroplasty | March 1, 2021 | March 1, 2025 |
| NCT05633810 | Recruiting | Phase 3 | COLchicine and Non-enteric Coated Aspirin in the Cardiovascular Outcomes Trial of Patients With Type 2 Diabetes | December 21, 2022 | December 2027 |
| NCT05625724 | Recruiting | Phase 3 | Aspirin for the Prevention of Preeclampsia and Pregnancy Outcomes After Assisted Reproductive Technology | August 2, 2023 | May 2026 |
| NCT04145258 | Recruiting | Phase 3 | Intensified Tuberculosis Treatment to Reduce the Mortality of Patients With Tuberculous Meningitis | February 7, 2021 | April 2026 |
| NCT04824911 | Recruiting | Phase 2 | Statin and Dual Antiplatelet Therapy to Prevent Early Neurological Deterioration in Branch Atheromatous Disease | March 23, 2021 | July 30, 2026 |
| NCT03796156 | Recruiting | Phase 3 | Aspirin to Target Arterial Events in Chronic Kidney Disease | February 25, 2019 | December 2025 |
| NCT05955365 | Recruiting | Phase 4 | Monotherapy With P2Y12 Inhibitors in Patients With Atrial fIbrillation Undergoing Supraflex Stent Implantation | December 18, 2023 | December 31, 2026 |
| NCT04088513 | Recruiting | Phase 4 | Safety and Efficacy of Aspirin in Stroke Patients With Glucose-6-phosphate Dehydrogenase Deficiency (SAST) | January 22, 2020 | December 31, 2024 |
| NCT03765619 | Recruiting | Early Phase 1 | Postoperative Aspirin and Ankle Fracture Healing | June 12, 2019 | January 1, 2025 |
| NCT04307511 | Recruiting | Phase 4 | A sTudy of Low Dose vs Standard Dose of tIcaGrelor on Platelet Function After intErvention for Acute Coronary syndRome in Diabetes Mellitus Patients | April 20, 2020 | May 31, 2024 |
| NCT04381936 | Recruiting | Phase 3 | Randomised Evaluation of COVID-19 Therapy | March 19, 2020 | June 30, 2036 |
| NCT03907046 | Recruiting | Phase 3 | Anticoagulation in ICH Survivors for Stroke Prevention and Recovery | January 28, 2020 | April 2027 |
| NCT04695106 | Recruiting | Phase 4 | Dual Antithrombotic Therapy With Dabigatran and Ticagrelor in Patients With ACS and Non-valvular AF Undergoing PCI | October 25, 2021 | March 31, 2026 |
| NCT05476081 | Recruiting | A REAl-life Study on Short-term DAPT in Patients With Ischemic Stroke or TIA | February 3, 2021 | May 3, 2023 | |
| NCT05462613 | Recruiting | Phase 2/Phase 3 | Regorafenib With Low-dose Chemotherapies and Aspirin Followed by Standard Chemotherapies in Metastatic Colorectal Cancer | May 9, 2023 | November 2030 |
| NCT05418556 | Recruiting | Phase 4 | Tailored Versus Coventional AntiPlaTelet Strategy Intended After OPTIMIZEd Drug Eluting Stent | October 21, 2022 | December 31, 2028 |
| NCT04418479 | Recruiting | Phase 4 | SMart Angioplasty Research Team: CHoice of Optimal Anti-Thrombotic Strategy in Patients Undergoing Implantation of Coronary Drug-Eluting Stents 3 | August 10, 2020 | December 31, 2024 |
| NCT04694248 | Recruiting | N/A | Anticoagulant Plus Antiplatelet Therapy Following Iliac Vein Stenting | November 3, 2021 | June 30, 2026 |
| NCT05411718 | Recruiting | Phase 2 | A Phase IIa Randomized, Double-Blinded Clinical Trial of Naproxen or Aspirin for Cancer Immune Interception in Lynch Syndrome | March 21, 2023 | November 30, 2025 |
| NCT03378934 | Recruiting | Phase 4 | Anti-platelet Effect of Berberine in Patients After Percutaneous Coronary Intervention | September 26, 2018 | June 2023 |
| NCT00725127 | Recruiting | Phase 4 | Chronotherapy With Low-dose Aspirin for Primary Prevention | October 2008 | June 2026 |
| NCT03079999 | Recruiting | Phase 2 | Study of Aspirin in Patients With Vestibular Schwannoma | June 11, 2018 | February 2029 |
| NCT05156879 | Recruiting | Phase 4 | Aspirin for the Management of Endometriosis-associated Pelvic Pain | December 23, 2021 | June 2025 |
| NCT04240834 | Recruiting | Phase 4 | Ticagrelor With Low-dose Versus Regular Aspirin in Patients With Acute Coronary Syndrome (ACS) at High-Risk for Ischemia After Percutaneous Coronary Intervention | February 1, 2021 | December 2026 |
| NCT04822363 | Recruiting | Early Phase 1 | The Accuracy Of A Novel Platelet Activity Assay In Humans On Antiplatelet Agents: Pharmacodynamics And Comparison With Light Transmission Aggregometry | August 20, 2021 | April 2025 |
| NCT05561660 | Recruiting | Phase 4 | COMParison of the EffecT of dEvice Closure in Alleviating Migraine With PFO (COMPETE-2) | October 1, 2022 | October 1, 2025 |
| NCT05125276 | Recruiting | Phase 4 | Less Bleeding by Omitting Aspirin in Non-ST-segment Elevation Acute Coronary Syndrome Patients | May 13, 2022 | July 2025 |
| NCT05986968 | Recruiting | N/A | The Safety of Ticagrelor Monotherapy After Primary Percutaneous Coronary Intervention for ST-elevation Myocardial Infarction and the Effect on Intramyocardial Haemorrhage | July 6, 2023 | July 6, 2025 |
| NCT05962034 | Recruiting | Phase 4 | Thromboxane Function in Women With Endometriosis | January 1, 2024 | August 1, 2027 |
| NCT03899987 | Suspended | Phase 2 | Aspirin and Rintatolimod With or Without Interferon-alpha 2b in Treating Patients With Prostate Cancer Before Surgery | November 29, 2019 | May 29, 2024 |
| NCT02748304 | Terminated | N/A | Sorafenib Combined With Aspirin to Prevent the Recurrence in High-risk Patients With Hepatocellular Carcinoma | April 2016 | February 11, 2019 |
| NCT00000157 | Terminated | Phase 3 | Randomized Trial of Aspirin and Cataracts in U.S. Physicians | April 1982 | January 1988 |
| NCT00004728 | Terminated | Phase 3 | Aspirin Or Warfarin To Prevent Stroke | July 2003 | |
| NCT00224679 | Terminated | Phase 3 | APACC Study:Prospective Study on Aspirin Efficacy in Reducing Colorectal Adenoma Recurrence | March 1997 | March 1999 |
| NCT00263211 | Terminated | Phase 2 | A Study of the Effects of Inhibiting Platelet Function on Circulating Cancer Cells in Breast Cancer Patients | January 2006 | September 2009 |
| NCT00384865 | Terminated | Phase 2 | A Study of Aspirin and Simvastatin in Pulmonary Arterial Hypertension | September 2006 | October 2009 |
| NCT00501345 | Terminated | Phase 3 | Aspirin in Patients With Myocardial Infarction and Thrombocytopenia | February 2002 | February 2008 |
| NCT00719537 | Terminated | N/A | Oral Progesterone and Low Dose Aspirin in the Prevention of Preeclampsia | July 2008 | March 2011 |
| NCT00732927 | Terminated | Phase 3 | Parnaparin vs Aspirin in the Treatment of Retinal Vein Occlusion | July 2002 | September 2007 |
| NCT00743197 | Terminated | N/A | Women With Chest Pain and Normal Coronary Arteries Study | May 2008 | May 2010 |
| NCT00748371 | Terminated | Phase 4 | Loss of Effect of Aspirin on Platelet Aggregation During Chronic Administration | June 2004 | February 2011 |
| NCT00790452 | Terminated | Phase 2 | Aspirin Prophylaxis for Venous Thromboembolism in Glioblastoma | November 2008 | October 2009 |
| NCT00946907 | Terminated | Phase 4 | Benign Acute Pericarditis: Brief Versus Longer Treatment Using Aspirin | July 2009 | July 2011 |
| NCT01158703 | Terminated | Phase 4 | Aspirin and Plavix Following Coronary Artery Bypass Grafting | July 2010 | December 2014 |
| NCT01547390 | Terminated | N/A | Early Prevention of Preeclampsia Study | March 2012 | July 20, 2015 |
| NCT01755520 | Terminated | Phase 3 | Study Comparing Ticagrelor With Aspirin for Prevention of Vascular Events in Patients Undergoing CABG | April 24, 2013 | May 19, 2018 |
| NCT01784159 | Terminated | Phase 2 | ASpirin for Patients With SEPsis and SeptIc Shock | March 27, 2019 | January 5, 2023 |
| NCT01965002 | Terminated | N/A | Feasibility of ExAblate MRI Guided High Intensity Focused Ultrasound Tx of Soft Tissue Tumors | May 2014 | March 24, 2015 |
| NCT02034292 | Terminated | Phase 1 | Safety Study of APD-791 With Aspirin and/or Clopidogrel | February 2014 | March 2014 |
| NCT02047539 | Terminated | Early Phase 1 | Randomized Controlled Trial of Aspirin vs Placebo in the Treatment of Pre-psychosis | January 2015 | March 2021 |
| NCT02072226 | Terminated | Phase 3 | A Study of the Efficacy and Safety of Alteplase in Participants With Mild Stroke | May 31, 2014 | March 22, 2017 |
| NCT02224235 | Terminated | N/A | COBRA SHIELD OCT Study | June 2014 | June 2015 |
| NCT02291419 | Terminated | Phase 4 | Study of Ticagrelor Versus Aspirin Treatment in Patients With Myocardial Injury Post Major Non-cardiac Surgery | July 2015 | June 2016 |
| NCT02333123 | Terminated | Phase 2 | Aspirin for Venous Ulcers: Randomised Trial (AVURT) | July 10, 2015 | November 11, 2016 |
| NCT02350543 | Terminated | Phase 4 | Peri-operative Aspirin Continuation Versus Discontinuation | February 2015 | June 2017 |
| NCT02396732 | Terminated | Phase 4 | Aspirin and Enoxaparin for VTE in Trauma | February 2016 | May 15, 2018 |
| NCT02407314 | Terminated | Phase 4 | Ticagrelor and Peripheral Arterial Disease | June 2015 | January 17, 2017 |
| NCT02419820 | Terminated | Phase 1 | Dose-escalation, Repeated and Single Oral Dosing Study | March 2015 | April 2016 |
| NCT02420652 | Terminated | Phase 2 | Metformin Hydrochloride and Aspirin in Treating Patients With Hormone-Dependent Prostate Cancer That Has Progressed After Surgery or Radiation Therapy | June 23, 2015 | December 1, 2019 |
| NCT02674958 | Terminated | Phase 3 | Mobilization of Endothelial Progenitor Cells and Aspirin | May 2016 | April 1, 2022 |
| NCT02786979 | Terminated | Phase 4 | Efficacy and Safety of Dorner Tablets and Aspirin for Prevention of Arteriosclerosis Progress in Type 2 Diabetes Mellitus Patients | July 2010 | January 2013 |
| NCT02927249 | Terminated | Phase 3 | Aspirin in Preventing Recurrence of Cancer in Patients With HER2 Negative Stage II-III Breast Cancer After Chemotherapy, Surgery, and/or Radiation Therapy | December 8, 2016 | February 15, 2023 |
| NCT02966002 | Terminated | Phase 4 | Aspirin as a Novel Anti-Inflammatory Modality in the Fontan Patients | April 2016 | May 25, 2017 |
| NCT03119012 | Terminated | Phase 4 | P2Y12 Inhibitor Monotherapy Versus Extended DAPT in Patients Treated With Bioresorbable Scaffold | April 19, 2017 | February 9, 2018 |
| NCT03170115 | Terminated | Phase 2 | Induction Chemotherapy Plus Chemoradiotherapy With or Without Aspirin in High Risk Rectal Cancer | November 30, 2017 | January 17, 2020 |
| NCT03192215 | Terminated | Phase 3 | AtRial Cardiopathy and Antithrombotic Drugs In Prevention After Cryptogenic Stroke | January 19, 2018 | April 17, 2023 |
| NCT03279809 | Terminated | N/A | The Effect of Aspirin on Patency of Metal Stent in Malignant Distal Bile Duct Obstruction | October 12, 2017 | September 5, 2020 |
| NCT03820466 | Terminated | Phase 3 | Effect of Platelet Inhibition and / or Lipid Lowering in Non-ACS-patients With Positive Troponin | February 21, 2020 | April 7, 2022 |
| NCT04456608 | Terminated | Phase 4 | Genetic and Dietary Predictors of Anti-platelet Response | August 1, 2016 | July 31, 2023 |
| NCT04498273 | Terminated | Phase 3 | COVID-19 Positive Outpatient Thrombosis Prevention in Adults Aged 40-80 | September 7, 2020 | August 5, 2021 |
| NCT03543683 | Unknown status | Combination of Osimertinib and Aspirin to Treat 1st Generation EGFR-TKI Resistance in NSCLC | August 1, 2020 | December 31, 2022 | |
| NCT03671174 | Unknown status | N/A | Immunosuppressant Regimens for Living Fetuses Study | August 2, 2019 | February 2023 |
| NCT03532698 | Unknown status | Combination of Osimertinib and Aspirin to Treat Osimertinib Resistance Non-small Cell Lung Cancer ( NSCLC) | August 1, 2020 | December 31, 2022 | |
| NCT03405974 | Unknown status | Phase 3 | Aspirin in the Prevention of Collapse in Osteonecrosis of the Hip | October 12, 2017 | November 1, 2021 |
| NCT03356769 | Unknown status | Phase 2 | Aspirin as an add-on Treatment of Refractory Epilepsy in Tuberous Sclerosis Complex | November 20, 2017 | November 20, 2021 |
| NCT03787927 | Unknown status | Phase 1/Phase 2 | Reversal of Dual Antiplatelet Therapy With Cold Stored Platelets | December 3, 2018 | December 3, 2021 |
| NCT03318744 | Unknown status | N/A | Antiplatelet Therapy for Silent Brain Infarction | January 2018 | December 2021 |
| NCT01157455 | Unknown status | Phase 4 | A Registry To Evaluate Safety And Effectiveness Of Everolimus Drug Eluting Stent For Coronary Revascularization | May 2010 | June 2013 |
| NCT01013532 | Unknown status | Phase 4 | PreventIon of CArdiovascular Events in iSchemic Stroke Patients With High Risk of Cerebral HemOrrhage | June 2009 | December 2016 |
| NCT00891670 | Unknown status | Phase 3 | Comparison of Platelet Inhibition With Adjunctive Cilostazol Versus High Maintenance-Dose Clopidogrel According to Hepatic Cytochrome 2C19 Allele (CYP2C19) Polymorphism | May 2009 | July 2009 |
| NCT00886574 | Unknown status | Phase 4 | Cilostazol Versus Aspirin for Primary Prevention of Atherosclerotic Events | April 2009 | February 2014 |
| NCT00776633 | Unknown status | Phase 4 | Triple Therapy in Patients on Oral Anticoagulation After Drug Eluting Stent Implantation | September 2008 | September 2014 |
| NCT00776477 | Unknown status | Phase 3 | The Clopidogrel and Aspirin After Surgery for Coronary Artery Disease | December 2007 | |
| NCT00775762 | Unknown status | Phase 3 | Anti-Inflammatory and Anti-Platelet Effect of Clopidogrel and Aspirin vs Aspirin Alone in Symptomatic Polyvascular Disease and in Patients With Multiple Recurrent Cardiovascular Events | November 2008 | December 2010 |
| NCT00724724 | Unknown status | Phase 4 | The Effectiveness and Safety of Butylphthalide Soft Capsules in Secondary Prevention of Ischemic Stroke Trial | August 2008 | August 2011 |
| NCT00578760 | Unknown status | N/A | Does Aspirin Have a Protective Role Against Chemotherapeutically Induced Ototoxicity? | February 2008 | February 2010 |
| NCT00482261 | Unknown status | Phase 2 | A Study of Low Dose Lenalidomide and Dexamethasone in Relapsed/Refractory Myeloma in Patients at High Risk for Myelosuppression | June 2007 | September 2013 |
| NCT00427271 | Unknown status | Phase 4 | Aspirin and Enalapril in Microalbuminuric Type 2 Diabetes Mellitus Patients | March 2003 | January 2007 |
| NCT00357682 | Unknown status | Phase 3 | A Phase III, Randomized, Study of Aspirin and Esomeprazole Chemoprevention in Barrett's Metaplasia | March 2005 | May 2017 |
| NCT00225849 | Unknown status | Phase 4 | Japanese Primary Prevention Project With Aspirin | March 2005 | September 2010 |
| NCT03574909 | Unknown status | Phase 3 | IRELAnD: Investigating the Role of Early Low-dose Aspirin in Diabetes | September 2018 | September 2021 |
| NCT03620760 | Unknown status | Phase 4 | Efficacy and Safety of Low Dose Ticagrelor in Patients With Unstable Angina Pectoris After Coronary Stent Implantation | August 7, 2018 | December 31, 2020 |
| NCT03661463 | Unknown status | Phase 2 | Unruptured Intracranial Aneurysm Aspirin Trial (UIAAT). | October 24, 2019 | December 2019 |
| NCT03266731 | Unknown status | N/A | Role of Anti-platelet in Treatment of Acute Ischemic Stroke | January 4, 2018 | January 4, 2020 |
| NCT03263299 | Unknown status | Phase 4 | Value of Cabergoline and Low Dose Aspirin in Poor Responders Undergoing ICSI-ET With GnRH Agonist Flare-Up-Protocol | August 2017 | September 2018 |
| NCT00222677 | Unknown status | Phase 2/Phase 3 | Aspirin for the Prevention of Recurrent Venous Thromboembolism | May 2004 | |
| NCT03188471 | Unknown status | Phase 4 | Preventive Application of GnRH Antagonist on Early OHSS | January 2017 | March 2018 |
| NCT03128346 | Unknown status | N/A | Analgesic Effects of Transversus Thoracic Plane (TTP) Block in Cardiac Surgery | October 1, 2017 | May 1, 2018 |
| NCT03112707 | Unknown status | Phase 4 | Bioresorbable Polymer-Coated EES in Patients at High Bleeding Risk Undergoing PCI Followed by 1-Month DAPT | April 14, 2017 | May 1, 2020 |
| NCT03078257 | Unknown status | Phase 1 | Different Platelet Activities Between Intracoronary and Peripheral Blood in Coronary Artery Disease Patients | January 1, 2016 | December 2017 |
| NCT03049085 | Unknown status | Phase 4 | Effect of Preoperative Aspirin in Patients Undergoing Off-pump Coronary Artery Bypass Grafting | February 1, 2017 | May 2019 |
| NCT02990403 | Unknown status | Phase 4 | The Novel Immunomodulatory and Anticoagulant Therapies for Recurrent Pregnancy Loss | October 2014 | December 22, 2018 |
| NCT02986594 | Unknown status | Phase 4 | Diagnosis and Treatment Strategy of Recurrent Spontaneous Abortion Associated With Thrombophilla | November 2016 | October 2019 |
| NCT02975076 | Unknown status | N/A | Sanchitongtshu Plus Asprine for Minor Ischemic Stroke or Transient Ischemic Attack: A Randomized Double-blind Study | December 2016 | November 2019 |
| NCT02974920 | Unknown status | Phase 4 | Rivaroxaban or Aspirin for Biological Aortic Prosthesis | January 1, 2017 | November 2022 |
| NCT02970604 | Unknown status | Phase 4 | PPARGC1β and CNTN4 Genotype Aspirin Study | May 2016 | February 2018 |
| NCT02960126 | Unknown status | Phase 3 | Efficacy and Safety of Aspirin and Clopidogrel in the Atrial Fibrillation With Low or Moderate Stroke Risk | November 2016 | October 2021 |
| NCT04142151 | Unknown status | N/A | Double Randomized and Placebo Controlled Trail of Sanchitongshu Combined Antiplatelet Drug to Prevent Ischemic Stroke | September 1, 2019 | December 31, 2020 |
| NCT02929888 | Unknown status | Phase 2/Phase 3 | Study of Platelet Function After Administration of Aspirin Versus Lysine Acetylsalicylate in STEMI Patients | October 2016 | |
| NCT02895113 | Unknown status | Phase 3 | Aspirin and Renal Disease Progression in Patients With Type 2 Diabetes | January 2017 | September 2018 |
| NCT04269863 | Unknown status | N/A | Personalizing Aspirin Therapy in Peripheral Arterial Disease Patients | November 1, 2020 | November 2021 |
| NCT02837003 | Unknown status | 3-Month Discontinuation of Dual Antiplatelet Therapy After Ultimaster Sirolimus-Eluting Stent Implantation | July 2016 | March 2019 | |
| NCT02770274 | Unknown status | Phase 3 | Cilostazol Following Peripheral Endovascular Procedures | December 2016 | December 2021 |
| NCT04308551 | Unknown status | N/A | Effect of Indobufen and Aspirin on Platelet Aggregation and Long Term Prognosis in Patients With Coronary Heart Disease | December 30, 2021 | December 1, 2022 |
| NCT02757365 | Unknown status | Phase 4 | Efficiency Study of Aspirin to Prevent the Occurrence of Prostate Cancer | April 2014 | April 2019 |
| NCT04327427 | Unknown status | Outcome Analysis of Aspirin in Liver Transplantation | October 1, 2019 | May 31, 2021 | |
| NCT02744937 | Unknown status | Phase 4 | Continuing Low Dose Aspirin Before Prostate Biopsy | April 2016 | |
| NCT02694848 | Unknown status | Phase 4 | Clinical Study of Combination Therapy for Angina of Coronary Heart Disease With Aspirin and Salvianolate Injection | February 2016 | March 2017 |
| NCT02678221 | Unknown status | Phase 2 | Sildenafil Citrate for the Management of Asymmetrical Intrauterine Growth Restriction | February 2016 | April 2017 |
| NCT04407312 | Unknown status | Phase 4 | Cilostazol and Endothelial Progenitor Cell | January 1, 2016 | July 31, 2020 |
| NCT02602938 | Unknown status | Phase 2 | Aspirin on CTCs of Advanced Breast and Colorectal Cancer | November 2015 | February 2017 |
| NCT04425590 | Unknown status | Phase 2/Phase 3 | The Benefit of Add On DLBS1033 for Ischemic Stroke Patient | April 1, 2020 | August 2020 |
| NCT04434365 | Unknown status | Phase 1/Phase 2 | Effect of Berberine for Endothelial Function and Intestinal Microflora in Patients With Coronary Artery Disease | June 21, 2019 | December 30, 2020 |
| NCT00000161 | Unknown status | Phase 3 | Randomized Trials of Vitamin Supplements and Eye Disease | August 1993 | |
| NCT02483169 | Unknown status | Phase 4 | PreventIon of IMT Progression in iSchemic Stroke Patients With High Risk of Cerebral HemOrrhage-IMT Study | June 2009 | December 2016 |
| NCT00000152 | Unknown status | Phase 3 | Randomized Trial of Beta-Carotene and Macular Degeneration | April 1982 | |
| NCT04631627 | Unknown status | Phase 4 | Early Prediction and Randomised Prevention of Preeclampsia With Low Dose Aspirin in Chinese Cohort | November 16, 2020 | August 30, 2022 |
| NCT02402491 | Unknown status | Phase 4 | Twelve vs 24 Months of Dual Antiplatelet Therapy in Patients With Coronary Revascularization for In-stent Restenosis | January 2013 | June 2015 |
| NCT04656665 | Unknown status | Phase 4 | The Effectiveness of Aspirin on Preventing Pre-eclampsia | March 15, 2021 | December 31, 2022 |
| NCT04685642 | Unknown status | Phase 4 | Anti-inflmmation Treatment in Mood Disorder and Deep Learning Prediction Model | August 24, 2020 | July 31, 2023 |
| NCT02387086 | Unknown status | Phase 2/Phase 3 | Gefitinib Combined With Thalidomide to Treat NSCLC | May 2015 | May 2017 |
| NCT02359643 | Unknown status | N/A | Multi-center Prospective Randomized Control Trail of High Dose Aspirin in Acute Stage of Kawasaki Disease | May 2013 | April 2017 |
| NCT02238444 | Unknown status | Phase 4 | Warfarin Prevents Portal Vein Thrombosis in Liver Cirrhotic Patients With Hypersplenism After Laparoscopic Splenectomy | September 1, 2014 | September 30, 2019 |
| NCT04754789 | Unknown status | Phase 3 | Effect of Upstream Treatment With High Intensity Statin on the Outcomes of STMI Patients Treated With PPCI | February 20, 2021 | March 1, 2021 |
| NCT02221102 | Unknown status | Phase 2/Phase 3 | Edoxaban for TIA and Acute Minor Stroke | December 2013 | June 2016 |
| NCT02201667 | Unknown status | Phase 4 | Efficacy of Ticagrelor vs Clopidogrel in High-risk NSTE-ACS Patients Undergoing Early PCI | August 2014 | October 2016 |
| NCT04809818 | Unknown status | Phase 1 | A Study to Evaluate Safety and PK of Multiple Doses of LT3001 Drug Product and Drug-drug Interaction in Healthy Subjects | March 21, 2021 | October 19, 2021 |
| NCT02084615 | Unknown status | N/A | Prospective Study Investigating Aspirin and Intraoperative Blood Loss and Complications Following Inguinal Hernia Repair | August 2014 | June 2017 |
| NCT02055131 | Unknown status | Phase 4 | Antiaggregation in Primary Prevention of Vascular Access for Hemodialysis | November 2013 | March 2015 |
| NCT01968798 | Unknown status | Phase 4 | ASPREE Cancer Endpoints Study | September 2013 | April 2024 |
| NCT01936233 | Unknown status | Phase 3 | Clinical Study of Antiviral and Aspirin Treatment in Liver Cancer After Radical Surgery | August 2013 | December 2023 |
| NCT01932203 | Unknown status | Phase 4 | Efficacy Study of Cilostazol and Aspirin on Cerebral Small Vessel Disease | July 17, 2013 | August 31, 2019 |
| NCT01924325 | Unknown status | Phase 2/Phase 3 | Apixaban Versus Dual-antiplatelet Therapy (Clopidogrel and Aspirin) in Acute Non-disabling Cerebrovascular Events | January 2014 | July 2016 |
| NCT01923818 | Unknown status | Phase 2/Phase 3 | Treatment of Rivaroxaban Versus Aspirin for Non-disabling Cerebrovascular Events | September 2013 | April 2016 |
| NCT01917799 | Unknown status | Phase 4 | Aspirin, Heparin and Miscarriage | January 2009 | December 2013 |
| NCT01890005 | Unknown status | Phase 3 | Low Dose Aspirin for the Prevention of Preeclampsia | July 2013 | January 2014 |
| NCT01872858 | Unknown status | N/A | Efficacy and Safety of Cilostazol in Patients of Vascular Cognitive Impairment-no Dementia (VCIND) | November 2010 | November 2015 |
| NCT01800357 | Unknown status | Phase 2 | Efficacy and Safety of Mildronate for Acute Ischemic Stroke | January 2013 | August 2014 |
| NCT05151796 | Unknown status | Continuation of Aspirin Before Isolated Heart Valve Surgery | May 1, 2012 | December 1, 2021 | |
| NCT01786200 | Unknown status | N/A | Physiological Effects of Altering Cancer-related Inflammation | February 2013 | |
| NCT01768260 | Unknown status | N/A | Effect of EECP on Anterior Ischemic Optic Neuropathy | December 2012 | March 2018 |
| NCT01709994 | Unknown status | Phase 3 | Primary Cardiovascular Risk Prevention With Aspirin in Chronic Kidney Disease Patients | May 2010 | May 2015 |
| NCT01635426 | Unknown status | Phase 2/Phase 3 | Aspirin Versus Clopidogrel Effect on Uterine Blood Flow in Women With Unexplained Recurrent Miscarriages | March 2012 | March 2018 |
| NCT05343429 | Unknown status | Phase 4 | Preoperative Aspirin and Benzydamine Hydrochloride Gargles on Severity and Duration of Post-Operative Sore Throat | April 1, 2022 | December 31, 2022 |
| NCT01598337 | Unknown status | Phase 3 | The Effect Of Antiplatelets Therapy On Saphenous Vein Coronary Artery Bypass Graft Patency | April 2011 | |
| NCT01518231 | Unknown status | Phase 1 | Autologous Hematopoietic Stem Cell Transplantation in Ischemic Stroke | January 2012 | December 2013 |
| NCT01496521 | Unknown status | Phase 3 | Chemoprevention of Esophageal Squamous Cell Carcinoma (ESCC) With Aspirin and Tea Polyphenols | January 2012 | January 2013 |
| NCT01466452 | Unknown status | Phase 2 | Antiplatelet Effect of Low Doses of Aspirin Taken Every 12 Hours in Patients Undergoing Coronary Artery Bypass Graft and/or Aortic Valve Surgery | September 2011 | September 2013 |
| NCT01465256 | Unknown status | N/A | Postpolypectomy Bleeding in Patients With Antiplatelet Therapy | April 2012 | June 2014 |
| NCT01431053 | Unknown status | Phase 2 | Study of Aspirin and Exemestane as Adjuvant Treatment in Breast Cancer | July 2011 | July 2014 |
| NCT01375400 | Unknown status | N/A | Effect of Aspirin at the Acute Phase of Cerebral Ischemic Event. | December 2010 | |
| NCT01268917 | Unknown status | Phase 3 | The Effects of Preoperative Aspirin on Graft Patency and Cardiac Events in Off-pump Coronary Artery Bypass | March 2010 | |
| NCT01250340 | Unknown status | Phase 4 | Type 2 Diabetes Mellitus and Atherosclerosis | August 2010 | December 2012 |
| NCT01211925 | Unknown status | Phase 2/Phase 3 | Distal Venous Arterialisation of Ischemic Limb | September 2009 | July 2011 |
| NCT03794596 | Withdrawn | Phase 2 | A Proof of Concept, Window Trial of the IMmunological Effects of AveLumab and Aspirin in Triple-Negative Breast Cancer | September 2019 | February 28, 2021 |
| NCT00940784 | Withdrawn | Phase 2 | Clopidogrel and Aspirin for the Treatment of Polycythemia Vera | June 2009 | January 2011 |
| NCT01198379 | Withdrawn | Phase 4 | Aspirin in the Prevention of Cardiovascular Events in Hemodialysis Patients | February 2010 | January 15, 2018 |
| NCT03232450 | Withdrawn | N/A | Patent Foramen Ovale (PFO) Closure at the Time of Endovascular Cardiac Electronic Device Implantation | August 2019 | December 2023 |
| NCT04343001 | Withdrawn | Phase 3 | Coronavirus Response - Active Support for Hospitalised Covid-19 Patients | October 2020 | August 2021 |
| NCT02433587 | Withdrawn | Phase 3 | Short vs Long Duration Dual Antiplatelet Therapy in Patients Undergoing Lower Extremity Endovascular Revascularization | October 2019 | July 2023 |
| NCT04535518 | Withdrawn | Phase 3 | Efficacy of Immunoglobulin Plus Infliximab for the Early Regression of Coronary Artery Lesion in Kawasaki Disease | October 2020 | September 2022 |
| NCT02866448 | Withdrawn | N/A | Impact of isoQUercetin and Aspirin on Platelet Function | August 2016 | October 2016 |
| NCT04557475 | Withdrawn | Phase 3 | Transplacental Aspirin Therapy for Early Onset Fetal Growth Restriction | June 11, 2022 | June 11, 2023 |
| NCT00265408 | Withdrawn | Phase 1 | Pilot Study of Aspirin Versus Warfarin for Cervicocephalic Arterial Dissection | December 2005 | March 2007 |
| NCT03027167 | Withdrawn | Phase 4 | Outcomes Study in Patients Receiving Aspirin With Mechanical Compression Devices Versus Aspirin Alone Following Knee and Hip Arthroplasty | January 2017 | January 2023 |
| NCT02832531 | Withdrawn | Phase 3 | INVestIgation of rheumatiC AF Treatment Using Vitamin K Antagonists, Rivaroxaban or Aspirin Studies, Superiority | January 2022 | August 2022 |
| NCT00417898 | Withdrawn | Phase 1 | Study of Aspirin and TPA in Acute Ischemic Stroke | March 2007 | December 2012 |
| NCT01668901 | Withdrawn | Phase 4 | Warfarin Versus Aspirin in Patients With Atrial Fibrillation and Chronic Kidney Disease | September 2012 | June 2016 |
| NCT04038489 | Withdrawn | Phase 2 | COX Inhibition and Biomarkers During Neoadjuvant Chemoendocrine Therapy for ER+, HER2- Stage I-III Breast Cancer | October 18, 2019 | April 30, 2023 |
| NCT00942617 | Withdrawn | N/A | Measurement of Platelet Dense Granule Release in Healthy Volunteers | July 2009 | June 2012 |